Abbott Nutrition

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Abbott Nutrition sits in the top decile of US sponsors by registered trial count (#263 of 15,742 sponsors by registered trial count).

89 total trials 1 currently recruiting 75 completed top decile by trial count

Abbott Nutrition: 89 sponsored US clinical trials, 1 recruiting.

Abbott Nutrition sponsors 89 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 75 completed. 18 of these trials are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Gastrointestinal Tolerance, with 5 trials.

Top-decile sponsor footprint

Abbott Nutrition ranks in the top decile of sponsors by registered trial count (#263 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 58/100

75 of 86 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

89 total, page 2 of 2

COMPLETED NA

Evaluation of an Oral Nutritional Supplement

NCT01781624

COMPLETED Phase 3

A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study

NCT01626742

COMPLETED Phase 3

Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula

NCT01573871

COMPLETED Phase 3

Comparison of Medical Nutritional Supplements

NCT01483976

COMPLETED Phase 2

Nutrition Beverage Tolerance Study

NCT01464385

TERMINATED Phase 3

Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients

NCT01477723

COMPLETED

Ex Vivo Exploratory Analysis in Healthy Full-term Infants

NCT01573884

COMPLETED Phase 3

Evaluation of a Novel Human Milk Fortifier in Preterm Infants

NCT01373073

COMPLETED Phase 3

Growth and Tolerance of Young Infants Fed Infant Formulas

NCT01380886

COMPLETED Phase 3

Healthy Term Infants Fed Milk-Based Formulas

NCT01617889

COMPLETED Phase 3

Evaluation of an Oral Nutritional Supplement Containing AN777

NCT01191125

COMPLETED Phase 2

Post Prandial Glucose Control Proof-of-Principle

NCT01326299

COMPLETED Phase 2

Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics

NCT01324921

TERMINATED Phase 3

Growth and Tolerance of Healthy Term Infants to a New Infant Formula

NCT01137877

COMPLETED Phase 3

Tolerance of Healthy Term Infants Fed Infant Formulas #4

NCT01155414

COMPLETED Phase 1

Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery

NCT00945581

COMPLETED Phase 3

Tolerance of Healthy Term Infants Fed Infant Formulas #3

NCT00977964

COMPLETED Phase 2

Glucose Tolerance in Healthy Overweight Adults

NCT00974831

COMPLETED Phase 2

Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants

NCT00798382

COMPLETED Phase 2

Evaluation of AN777 in Elderly Subjects

NCT00798291

COMPLETED Phase 3

Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes

NCT00753181

COMPLETED Phase 2

Tolerance of Healthy Term Infants Fed Infant Formulas

NCT00705562

COMPLETED Phase 3

Evaluation of a Medical Food for Chronic Wounds

NCT00711217

COMPLETED Phase 2

Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes

NCT00544206

COMPLETED Phase 2

Tolerance of Healthy, Term Infants to Infant Formulas

NCT00543673

COMPLETED Phase 2

Comparison of Nutritional Products for People With Type 2 Diabetes

NCT00520065

COMPLETED Phase 2

Tolerance and Development of Healthy, Term Infants

NCT00465764

COMPLETED Phase 2

Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

NCT00499148

COMPLETED Phase 3

Nutritional Study in Preterm Infants

NCT00707837

COMPLETED Phase 2

Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children

NCT01087710

COMPLETED Phase 3

Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas

NCT00540488

COMPLETED NA

Nutritional Management of Infants With Chronic Diarrhea

NCT01820494

COMPLETED NA

Growth of Infants Fed Hydrolysate Formulas

NCT02006992

COMPLETED NA

Infants With Protein Sensitive Colitis

NCT01813526

COMPLETED Phase 3

Growth of Infants Fed an Elemental Medical Food

NCT01699386

COMPLETED NA

Nutritional Management of Children With Chronic Diarrhea

NCT01812629

COMPLETED NA

Alternate Formula Feedings in Formula Intolerant Infants

NCT02456805

COMPLETED NA

Soy Formula Feedings in Healthy, Term Infants

NCT02456831

COMPLETED NA

Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amino Acid Metabolism in Infants

NCT02066610

← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 14
Phase 3 18

What is open in the Abbott Nutrition pipeline

1 recruiting of 89 indexed (1% open); 75 completed (84%).

Phase mix: 18 late (III/IV) vs 15 early (I/II) (balanced across stages).

Top condition: Gastrointestinal Tolerance (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Abbott Nutrition: open-pipeline peers nationwide

Peers matched on 89 registered trials and 1% open enrollment, not the therapeutic-area sidebar.

Abbott Nutrition sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 50100150200 0%10%20%30% Total trials Recruiting share Abbott NutritionFlorida International UniversityHackensack Meridian HealthModernaTXAbbVie (prior sponsor, Abbott)University of New MexicoAstellas PharmaBaxalta now part of ShireJohnson & Johnson Vision Care
Abbott Nutrition sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Abbott Nutrition sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 89 trials (± recruiting share)

Sponsors near 1% open enrollment (± trial volume)

What to do with this Abbott Nutrition page

89 registered trials is a research-attention snapshot, not an endorsement of Abbott Nutrition or any single study.

  • 1 of Abbott Nutrition's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Gastrointestinal Tolerance is the condition Abbott Nutrition studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gastrointestinal Tolerance trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Abbott Nutrition pipeline card: 89 registered trials from official public datasets.Report a data error.